Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues-Reference-Cited by-同舟云学术

Daptomycin Physiology-Based Pharmacokinetic Modeling to Predict Drug Exposure and Pharmacodynamics in Skin and Bone Tissues

Published:2022-08-16 Issue:10 Volume:61 Page:1443-1456
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Garreau Romain^ORCID,Montange Damien,Grillon Antoine,Jehl François,Ferry Tristan,Bourguignon Laurent,Goutelle Sylvain

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-022-01168-5.pdf

Reference46 articles.

1. Straus SK, Hancock REW. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta. 2006;1758:1215–23. https://doi.org/10.1016/j.bbamem.2006.02.009.

2. US FDA. FDA approved drug products: Cubicin (daptomycin) injection. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208385s005lbl.pdf. Accessed 7 Aug 2022.

3. Jones TW, Jun AH, Michal JL, Olney WJ. High dose daptomycin and clinical applications. Ann Pharmacother. 2021;55:1363–78. https://doi.org/10.1177/1060028021991943.

4. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:1–10. https://doi.org/10.1093/cid/cis966.

5. Roux S, Valour F, Karsenty J, Gagnieu M-C, Perpoint T, Lustig S, et al. Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center. BMC Infect Dis. 2016;16:83. https://doi.org/10.1186/s12879-016-1420-7.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daptomycin Dosage Optimization in Renal Impairment Using Model-Informed Precision Dosing;Therapeutic Drug Monitoring;2024-09-10

2. Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2024-02-07

3. Reply to Tannous et al.;Clinical Infectious Diseases;2024-01-17

4. Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis;European Journal of Drug Metabolism and Pharmacokinetics;2023-03

5. Predictive Performance of Physiologically Based Pharmacokinetic Modelling of Beta-Lactam Antibiotic Concentrations in Adipose, Bone, and Muscle Tissues;Drug Metabolism and Disposition;2023-01-13